These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6353898)

  • 1. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.
    Higginbotham MB; Morris KG; Bramlet DA; Coleman RE; Cobb FR
    Am J Cardiol; 1983 Oct; 52(7):782-8. PubMed ID: 6353898
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D
    Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure.
    Goldman SA; Johnson LL; Escala E; Cannon PJ; Weiss MB
    Am J Med; 1980 Jan; 68(1):36-42. PubMed ID: 7350803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I; Tweddel AC; Bastian BC; Murray RG
    Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of prazosin in therapy-resistant chronic cardiac failure (author's transl)].
    Lemke R; Trompler A; Kaltenbach M; Bussmann WD
    Dtsch Med Wochenschr; 1979 Dec; 104(50):1769-73. PubMed ID: 510213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects at rest and during exercise in long-term treatment with prazosin in chronic congestive heart failure.
    Westheim A; Koss A; Sivertssen E
    Acta Med Scand; 1986; 219(5):449-53. PubMed ID: 3526819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA; Chatterjee K; Gelberg HJ; Ports TA; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy of heart failure with prazosin: a randomized double blind trial.
    Colucci WS; Wynne J; Holman BL; Braunwald E
    Am J Cardiol; 1980 Feb; 45(2):337-44. PubMed ID: 6766650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
    Tomov I; Kaloianova A; Terzieva L; Nikolov G; Elenkova A
    Vutr Boles; 1982; 21(6):45-50. PubMed ID: 6761964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rest and exercise haemodynamic patterns with chronic prazosin or beta-blocker therapy in hypertensive cardiomegaly.
    Nelson GI; Hunyor SN; Donnelly GL
    Med J Aust; 1980 Jul; 2(SP1):39-41. PubMed ID: 6106881
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term therapy with prazosin in severe chronic congestive heart failure.
    Bertel O
    Cardiology; 1980; 65 Suppl 1():70-3. PubMed ID: 7379073
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic effects of sustained treatment with prazosin and metoprolol, alone and in combination, in borderline hypertensive heart failure.
    Nelson GI; Donnelly GL; Hunyor SN
    J Cardiovasc Pharmacol; 1982; 4(2):240-5. PubMed ID: 6175807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.
    Rubin SA; Chatterjee K; Parmley WW
    Circulation; 1980 Mar; 61(3):543-8. PubMed ID: 7353245
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
    Greenberg BH; Massie BM
    Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
    [No Abstract]   [Full Text] [Related]  

  • 18. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.